J.W. Cole Advisors’s Biogen BIIB Stock Holding History

J.W. Cole Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,991	Closed	-$279K	–	1474
2025 Q3	$279K	Sell	1,991 -26	-1%	-$3.51K	0.01%	1252
2025 Q2	$253K	Buy	+2,017	New	+$251K	0.01%	1227

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

J.W. Cole Advisors's BIIB Position: Q4 2025 in Review

J.W. Cole Advisors sold out of Biogen (BIIB) in Q4 2025, closing a stake of 1,991 shares — an estimated $279K sold.

J.W. Cole Advisors first reported a position in BIIB in Q2 2025 and held it in 2 quarters. The position peaked at $279K in Q3 2025. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

J.W. Cole Advisors reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
J.W. Cole Advisors sold 1,991 Biogen shares in Q4 2025, an estimated $279K.
J.W. Cole Advisors first reported a position in Biogen in Q2 2025 and held it in 2 quarters.
J.W. Cole Advisors's Biogen position peaked at $279K in Q3 2025.
997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on J.W. Cole Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.